BE898057A - Traitement de la calvitie androide. - Google Patents

Traitement de la calvitie androide.

Info

Publication number
BE898057A
BE898057A BE0/211754A BE211754A BE898057A BE 898057 A BE898057 A BE 898057A BE 0/211754 A BE0/211754 A BE 0/211754A BE 211754 A BE211754 A BE 211754A BE 898057 A BE898057 A BE 898057A
Authority
BE
Belgium
Prior art keywords
calvitis
android
treatment
lower limit
normal range
Prior art date
Application number
BE0/211754A
Other languages
English (en)
Original Assignee
Mortimer Christopher H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mortimer Christopher H filed Critical Mortimer Christopher H
Publication of BE898057A publication Critical patent/BE898057A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne un procédé pour réduire la perte des cheveux chez l'homme, caractérisé en ce que l'on administre à un homme, une composition pharmaceutique comprenant un ingrédient actif qui, par son administration, provoque un abaissement des taux en dihydrotestostérone du plasma jusqu'à une valeur sensiblement en-dessous de la limite inférieure de la plage normale, tout en n'abaissant pas le taux en testostérone du plasma en-dessous de la limite inférieure de la plage normale dans une mesure telle qu'elle provoquerait un disfonctionnement sexuel.
BE0/211754A 1982-10-21 1983-10-21 Traitement de la calvitie androide. BE898057A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43579882A 1982-10-21 1982-10-21

Publications (1)

Publication Number Publication Date
BE898057A true BE898057A (fr) 1984-02-15

Family

ID=23729847

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/211754A BE898057A (fr) 1982-10-21 1983-10-21 Traitement de la calvitie androide.

Country Status (3)

Country Link
BE (1) BE898057A (fr)
DE (1) DE3338339A1 (fr)
ZA (1) ZA837859B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046279A3 (fr) * 1998-03-11 2001-02-22 Endorech Inc INHIBITEURS DE LA 17β-HYDROXYSTEROIDE DESHYDROGENASE DU TYPE 5 ET DU TYPE 3 ET METHODES D'UTILISATION ASSOCIEES

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
EP0240630A3 (fr) * 1986-04-10 1989-01-25 University Of Miami Traitement de l'hyperandrogénie de la peau utilisant des compositions contenant du pregnénolone
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
DE4100975A1 (de) * 1991-01-15 1992-07-16 Weuffen Wolfgang Kosmetische oder pharmazeutische zubereitungen zur verbesserung der haarqualitaet und foerderung des haarwachstums
DE4214953C2 (de) * 1992-05-06 1995-05-18 Arrowdean Ltd Arzneimittel zur Erhöhung des Testosteronspiegels

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046279A3 (fr) * 1998-03-11 2001-02-22 Endorech Inc INHIBITEURS DE LA 17β-HYDROXYSTEROIDE DESHYDROGENASE DU TYPE 5 ET DU TYPE 3 ET METHODES D'UTILISATION ASSOCIEES
US6541463B1 (en) 1998-03-11 2003-04-01 Endorecherche, Inc. Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use

Also Published As

Publication number Publication date
DE3338339A1 (de) 1984-04-26
ZA837859B (en) 1984-11-28

Similar Documents

Publication Publication Date Title
ES8308213A1 (es) Procedimiento para preparar una composicion farmaceutica topica que contiene una mezcla de un agente antimicrobiano de acido graso y un corticosteroide.
ES2160631T3 (es) Composiciones de retinoides para aplicacion topica.
TNSN95061A1 (fr) Derives d'oxalylamino-benzofuranne et benzothienyle
AR055050A1 (es) Composicion farmaceutica que comprende n-etil-9a, 11a, 15s- trihidoxi-17-fenil-18,19,20-trinor-prosta -5z, 13e- dien-1-amida (bimatoprost) y cloruro de benzalconio, y uso de estos compuestos par la preparacion de la misma
MX9300690A (es) Composiciones de champu y agente de suspension del mismo.
NZ234143A (en) Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
WO1998005323A3 (fr) Procede de regulation du systeme reproducteur femelle au moyen d'inhibiteurs de l'angiogenese
RU93058524A (ru) Системы с регулируемым высвобождением и низкими дозами андрогенов, способ их получения и способ лечения с помощью этих систем
AU5348194A (en) Method of preventing nmda receptor complex-mediated neuronal damage
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
TNSN99132A1 (fr) Une composition pour la prevention et/ou le traitement de l'osteoporose ou des alterations dues au syndrome de menopause
UY25067A1 (es) Acetato de sertralina, composiciones farmacéuticas que lo contienen y procedimientos de preparación.
TNSN95098A1 (fr) Derives de cycloalcanoindoles et de cycloalcanoaza-indoles
DE69311361D1 (de) Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
MXPA02000437A (es) Composicion para el tratamiento de trastornos de secrecion externa.
BE898057A (fr) Traitement de la calvitie androide.
PE17797A1 (es) Composicion detergente
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
DE59309877D1 (de) Gel, insbesondere für die Augenheilkunde
FR2397682A1 (fr) Procede et dispositif pour la construction d'une image par tomographie
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
AU2002211577A1 (en) Protecting therapeutic compositions from host-mediated inactivation
DK0506563T3 (da) Alginsyresuspension
DK0654267T3 (da) Carcinostatisk middel til hormonterapi indeholdende dienogest som aktiv komponent
JPS5657102A (en) Automatic control system of farming machine

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MORTIMER CHRISTOPHER H.

Effective date: 19891031